| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 1996;28:1081-1084.)
© 1996 American Heart Association, Inc.
Articles |
Influence of the Angiotensin II Type 1 Receptor Gene Polymorphism on the Effects of Perindopril and Nitrendipine on Arterial Stiffness in Hypertensive Individuals
Institut National de la Sante et de la Recherche Medicale (INSERM) U337, Broussais Hospital (A.B., S.G., M.S., S.L., P.L.); INSERM SC7 (F.C., S.R., O.P.); and Institut de Formation et de Recherche Cardiovasculaire (J.T., R.A.), Paris, France.
Angiotensin-converting enzyme inhibitors improve arterial stiffness independently of blood pressure reduction. Since we have recently shown that in hypertensive individuals the A1166C polymorphism of the angiotensin II type 1 receptor (AT1-R) is an independent determinant of aortic stiffness, we designed the present study to assess the influence of this polymorphism on the changes of aortic stiffness after chronic treatment with the angiotensin-converting enzyme inhibitor perindopril and the calcium channel blocker nitrendipine. Forty perindopril- and 42 nitrendipine-treated hypertensive individuals were studied. We evaluated aortic stiffness by measuring the carotid-femoral pulse wave velocity. Carriers of the AT1-R C allele showed higher baseline values of pulse wave velocity than AA homozygotes (P<.05). In the perindopril group, a threefold greater reduction in pulse wave velocity was observed in carriers of the C allele than in AA homozygotes (-2.85±0.62 versus -0.94±0.32 m/s, respectively; P<.001), whereas in the nitrendipine group, pulse wave velocity decreased only in AA homozygotes and not in AT1-R C carriers (-1.38±0.35 versus +0.04±0.60 m/s, respectively; P<.01). These results indicate that according to the AT1-R A1166C genotype, an angiotensin-converting enzyme inhibitor and a calcium channel blocker affect pulse wave velocity in opposite ways. Since some evidence shows that increased pulse wave velocity may enhance cardiovascular risk, it might be useful for physicians to consider the AT1-R genotype when prescribing an angiotensin-converting enzyme inhibitor or calcium channel blocker to a hypertensive individual.
Key Words: genetics • renin-angiotensin system • calcium channel blockers • angiotensin-converting enzyme inhibitors • aorta
This article has been cited by other articles:
 |
|
 |
|
  P. Lacolley, P. Challande, M. Osborne-Pellegrin, and V. Regnault Genetics and pathophysiology of arterial stiffness Cardiovasc Res, March 1, 2009; 81(4): 637 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Rosskopf and M. C. Michel Pharmacogenomics of G Protein-Coupled Receptor Ligands in Cardiovascular Medicine Pharmacol. Rev., December 1, 2008; 60(4): 513 - 535. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-H. Lin, H.-C. Chiu, Y.-T. Lee, H.-M. Su, W.-C. Voon, H.-W. Liu, W.-T. Lai, and S.-H. Sheu Association Between Functional Polymorphisms of Renin-Angiotensin System, Left Ventricular Mass, and Geometry Over 4 Years in a Healthy Chinese Population Aged 60 Years and Older J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2007; 62(10): 1157 - 1163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B Jani and C Rajkumar Ageing and vascular ageing. Postgrad. Med. J., June 1, 2006; 82(968): 357 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bianco, T. Troiani, G. Tortora, and F. Ciardiello Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy Endocr. Relat. Cancer, July 1, 2005; 12(Supplement_1): S159 - S171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Baudin Polymorphism in angiotensin II receptor genes and hypertension Exp Physiol, May 1, 2005; 90(3): 277 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Amador, D. Oppenheimer, S. Perea, A. Maitra, G. Cusati, C. Iacobuzio-Donahue, S. D. Baker, R. Ashfaq, C. Takimoto, A. Forastiere, et al. An Epidermal Growth Factor Receptor Intron 1 Polymorphism Mediates Response to Epidermal Growth Factor Receptor Inhibitors Cancer Res., December 15, 2004; 64(24): 9139 - 9143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mahmud and J. Feely Review: Arterial stiffness and the renin-angiotensin-aldosterone system Journal of Renin-Angiotensin-Aldosterone System, September 1, 2004; 5(3): 102 - 108. [Abstract] [PDF]
|
|
|
|
 |
|
 J. J. Oliver and D. J. Webb Noninvasive Assessment of Arterial Stiffness and Risk of Atherosclerotic Events Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 554 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Anderson, J. F. Carlquist, B. D. Home, and J. B. Muhlestein Cardiovascular Pharmacogenomics: Current Status, Future Prospects Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2003; 8(1): 71 - 83. [Abstract] [PDF]
|
|
|
|
|
|
J.-J. Mourad, G. Ducailar, A. Rudnicki, M. Lajemi, A. Mimran, and M. E Safar Age-related increase of pulse pressure and gene polymorphisms in essential hypertension: a preliminary study Journal of Renin-Angiotensin-Aldosterone System, June 1, 2002; 3(2): 109 - 115. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Subramanian, M. D. Adams, J. C. Venter, and S. Broder Implications of the Human Genome for Understanding Human Biology and Medicine JAMA, November 14, 2001; 286(18): 2296 - 2307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M.A.B. Van Bortel, H. A.J. Struijker-Boudier, and M. E. Safar Pulse Pressure, Arterial Stiffness, and Drug Treatment of Hypertension Hypertension, October 1, 2001; 38(4): 914 - 921. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Dart and B. A. Kingwell Pulse pressure--a review of mechanisms and clinical relevance J. Am. Coll. Cardiol., March 15, 2001; 37(4): 975 - 984. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Safar Epidemiological Findings Imply That Goals for Drug Treatment of Hypertension Need to Be Revised Circulation, March 6, 2001; 103(9): 1188 - 1190. [Full Text] [PDF]
|
|
|
|
|
|
N. Padmanabhan, S. Padmanabhan, and J. M. Connell Genetic basis of cardiovascular disease -- the renin-angiotensin-aldosterone system as a paradigm Journal of Renin-Angiotensin-Aldosterone System, December 1, 2000; 1(4): 316 - 324. [PDF]
|
|
|
|
 |
|
 F. J. van Ittersum, A. M. E. de Man, S. Thijssen, P. de Knijff, E. Slagboom, Y. Smulders, L. Tarnow, A. J. M. Donker, H. J. G. Bilo, and C. D. A. Stehouwer Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus Nephrol. Dial. Transplant., July 1, 2000; 15(7): 1000 - 1007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.E Safar, C. Thuilliez, V Richard, and A Benetos Pressure-independent contribution of sodium to large artery structure and function in hypertension Cardiovasc Res, May 1, 2000; 46(2): 269 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Safar, J. Blacher, J. J. Mourad, and G. M. London Stiffness of Carotid Artery Wall Material and Blood Pressure in Humans : Application to Antihypertensive Therapy and Stroke Prevention Stroke, March 1, 2000; 31(3): 782 - 790. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. E. Evans and M. V. Relling Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics Science, October 15, 1999; 286(5439): 487 - 491. [Abstract] [Full Text]
|
|
|
|
|
|
M. E. Safar, G. M. London, R. Asmar, and E. D. Frohlich Recent Advances on Large Arteries in Hypertension Hypertension, July 1, 1998; 32(1): 156 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. F. Mitchell, L. A. Moye, E. Braunwald, J.-L. Rouleau, V. Bernstein, E. M. Geltman, G. C. Flaker, M. A. Pfeffer, and f. t. S. Investigators Sphygmomanometrically Determined Pulse Pressure Is a Powerful Independent Predictor of Recurrent Events After Myocardial Infarction in Patients With Impaired Left Ventricular Function Circulation, December 16, 1997; 96(12): 4254 - 4260. [Abstract] [Full Text]
|
|